Why the study?
What are the maternal and fetal outcomes in pregnant women with Eisenmenger's syndrome managed with a specific therapeutic strategy?
What are the maternal and fetal outcomes in pregnant women with Eisenmenger's syndrome managed with a specific therapeutic strategy?
Careful management of pregnant women with Eisenmenger's syndrome using bedrest, oxygen, diuretics, and timely cesarean section can achieve high maternal survival (92.3%), though fetal loss remains significant.
Supports specialized peripartum care in Eisenmenger syndrome; leaves open optimal fetal protection strategies.
AIM: To determine maternal and fetal outcomes in patients with Eisenmenger's syndrome (ES) with the therapeutic strategy. MATERIAL & METHODS: The case histories and therapeutic procedures of 13 pregnant women with ES had been reviewed. RESULTS: One case spontaneously aborted before 28 weeks due to intrauterine death, four were taken to cesarean section before 28 weeks and eight (61.5%) survived beyond 28 weeks' gestation before cesarean section. One mother died (92.3% survival), while infant loss was 38.5%. No pregnancy continued to term but eight babies delivered after 28 weeks were born alive, six of the children have normal physical and mental development. CONCLUSIONS: In pregnant women with ES who wish to continue pregnancy, treatment should include: prolonged bedrest, continuous oxygen inhalation, diuretic administration with close hemodynamic monitoring, anticoagulants should be avoided and exact time point selection of cesarean section.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: